Skip to main content
رجوع
KHTRF logo

Knight Therapeutics Inc.

جودة البيانات: 100%
ذروة شراء
KHTRF
OTC Healthcare Drug Manufacturers - Specialty & Generic
KWD 5.21
▲ KWD 0.13 (2.54%)
القيمة السوقية: 510.76M
نطاق اليوم
KWD 5.21 KWD 5.22
نطاق 52 أسبوعًا
KWD 3.91 KWD 5.22
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 4.40 / KWD 4.41
الإغلاق السابق
KWD 5.08

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (633 نظير)

المقياس السهم وسيط القطاع
P/E -95.1 0.2
P/B 0.7 2.9
ROE % -0.7 3.7
Net Margin % -1.2 3.9
Rev Growth 5Y % 16.6 10.0
D/E 0.1 0.2

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 16.58% annually over 5 years — strong growth
Earnings declined -223.95% over the past year
Debt/Equity of 0.10 — conservative balance sheet
Generating 68.34M in free cash flow
PEG of 0.50 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.54%

النمو

Revenue Growth (5Y)
16.58%
Revenue (1Y)21.12%
Earnings (1Y)-223.95%
FCF Growth (3Y)62.18%

الجودة

Return on Equity
-0.69%
ROIC-0.20%
Net Margin-1.19%
Op. Margin-0.49%

الأمان

Debt / Equity
0.10
Current Ratio2.39
Interest Coverage-0.21

التقييم

P/E Ratio
-95.12
Forward P/EN/A
P/B Ratio0.67
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 21.12% Revenue Growth (3Y) 17.06%
Earnings Growth (1Y) -223.95% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 16.58% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 449.72M Net Income (TTM) -5.37M
ROE -0.69% ROA -0.51%
Gross Margin 33.49% Operating Margin -0.49%
Net Margin -1.19% Free Cash Flow (TTM) 68.34M
ROIC -0.20% FCF Growth (3Y) 62.18%
Safety
Debt / Equity 0.10 Current Ratio 2.39
Interest Coverage -0.21
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -95.12 Forward P/E N/A
P/B Ratio 0.67 P/S Ratio 1.14
PEG Ratio 0.50 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 13.38%
Market Cap 510.76M Enterprise Value 512.22M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 449.72M 371.30M 328.20M 293.56M 243.48M
Net Income -5.37M 4.33M -16.84M -29.89M 15.68M
EPS (Diluted) -0.05 0.04 -0.16 -0.26 0.13
Gross Profit 150.62M 174.41M 152.65M 138.06M 115.41M
Operating Income -2.20M 7.40M -2.89M -2.40M -5.32M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.05B 963.80M 945.49M 1.05B 991.89M
Total Liabilities 278.80M 168.69M 198.62M 228.98M 149.87M
Shareholders' Equity 766.65M 795.11M 746.87M 825.86M 842.02M
Total Debt 77.85M 49.46M 69.09M 77.70M 40.96M
Cash & Equivalents 76.39M 80.11M 58.76M 71.68M 85.96M
Current Assets 394.51M 396.81M 365.12M 395.62M 307.32M
Current Liabilities 165.13M 111.25M 114.03M 141.32M 105.30M

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#515 of 829
36
Custom Full Throttle
#135 of 145
17

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 27, 2026
دخل Full Throttle
Mar 27, 2026